Clinical

Dataset Information

0

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

ABSTRACT: RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors understand how patients respond to treatment. PURPOSE: This laboratory study is looking at gene expression in patients with advanced or metastatic colorectal cancer receiving bevacizumab.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2072025 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
| 2072100 | ecrin-mdr-crc
Clinical S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304
| 2077690 | ecrin-mdr-crc
Clinical Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
| 2039514 | ecrin-mdr-crc
Clinical Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy
| 2025539 | ecrin-mdr-crc
Clinical Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581
| 2072004 | ecrin-mdr-crc
Clinical Immune Response in Peripheral Blood of Patients With Colon Cancer
| 2072210 | ecrin-mdr-crc
Clinical Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
| 2046477 | ecrin-mdr-crc
Clinical Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200
| 2072030 | ecrin-mdr-crc
Clinical Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer
| 2072126 | ecrin-mdr-crc
Clinical Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
| 2072517 | ecrin-mdr-crc